February 15, 2024Journal of Nuclear Medicine9 citationsOpen Access

PET/CT-Based Radiogenomics Supports KEAP1/NFE2L2 Pathway Targeting for Non–Small Cell Lung Cancer Treated with Curative Radiotherapy

VBVincent BourbonneInserm MMMoncef MorjaniCentre Hospitalier Régional Universitaire de Brest OPOlivier PradierInserm

Key Points

Key points are not available for this paper at this time.

Abstract

In lung cancer patients, radiotherapy is associated with a increased risk of local relapse (LR) when compared with surgery but with a preferable toxicity profile. The KEAP1/NFE2L2 mutational status (Mut

问 AI

Bookmark

View Full Paper

Cite This Study

Bourbonne et al. (Thu,) studied this question.

synapsesocial.com/papers/68e7907ab6db64358770192f https://doi.org/https://doi.org/10.2967/jnumed.123.266749

问 AI

Bookmark

View Full Paper